18F-FAPI-RGD PET/CT in Various Tumor Types - Trial NCT06094530
Access comprehensive clinical trial information for NCT06094530 through Pure Global AI's free database. This phase not specified trial is sponsored by Sichuan Provincial People's Hospital and is currently Recruiting. The study focuses on Neoplasms. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Sichuan Provincial People's Hospital
Timeline & Enrollment
N/A
Apr 10, 2023
Oct 01, 2024
Primary Outcome
Comparison of 18F-FAPI-RGD and 18F-FDG Uptake in Patients with different Tumors
Summary
The clinical feasibility of 18F-FAPI-RGD PET/CT will be evaluated in 100 patients with
 various types of tumor, and the results will be compared with those of 18F-FDG.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06094530
Non-Device Trial